Stock of MeiraGTx Holdings plc (MGTX) is rising about 5 percent on Thursday morning trading after the announcement of full-year 2025 financial results reporting narrower loss, and FDA's Breakthrough Designation for AAV2-hAQP1 treatment for Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tract.
The company's shares are currently trading at $8.04 on the Nasdaq, up 5.51 percent. The stock opened at $7.69 and has climbed as high as $8.54 so far in today's session. Over the past year, it has traded in a range of $4.55 to $9.73.
Loss declined to $114.2 million, or $1.42 a share, from $147.8 million, or $2.12 a share, last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.